Eclipse seeks exciting preclinical biotech companies developing novel therapeutics across all modalities and therapeutic areas.
The selection process is competitive, with up to four awards to be made annually. Selected companies will be offered an equity investment of up to $5 million from ALSA Ventures. Together with our partner ICON, we will work with selected companies on:
For further enquiries please email us at: firstname.lastname@example.org